Table 1.

The patient’s demographic data, clinical and angiographic outcome.

Characteristic	Results
Number of patients	24
Age	62 ± 10.3 (43–90)
Gender
Male	20 (83.3%)
Female	4 (16.7%)
Lesion location	30
ICA	6 (20%)
MCA	14 (46.6%)
BA	3 (10%)
VA	7 (23.3%)
Enterprise stent size
Diameter (mm)	4.5
Length (mm)	23.5 ± 4.4 (22–37)
Lesion characteristics
Mean pre-treated stenosis degree	81 ± 11.3%
Mean post-treated stenosis degree	18 ± 6.8%
Clinical outcome (mean follow-up of 15.8 months)
Morbidity (per lesion)
Post-procedural complication within 30 days (Early)	3 (10%)
Post-procedural complication 30 days later (Late)	0 (0%)
Modified Rankin Score (At presentation / at follow-up of at least 6 months)
Good (0–2)	16 (66%)/20 (83%)
Moderate to poor (3–6)	8 (34%)/4 (17 %)
Angiographic outcome (mean follow-up of 15.4 months)
Follow-up patients	17
Available follow-up lesions	20
In-stent restenosis	1/20 (5.0%)